Athyrium Capital Management

Latest statistics and disclosures from Athyrium Capital Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Athyrium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Athyrium Capital Management

Athyrium Capital Management holds 8 positions in its portfolio as reported in the March 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Amryt Pharma Sponsored ADS (AMYT) 46.3 $129M 8.9M 14.58
 View chart
Biora Note 7.250% 12/0 (Principal) 20.8 $58M 104M 0.56
 View chart
Omeros Corp Note 5.250% 2/1 (Principal) 16.7 $47M +12% 65M 0.71
 View chart
Rvl Pharmaceuticals SHS (RVLP) 6.0 $17M 15M 1.14
 View chart
Omeros Corp Note 6.250%11/1 (Principal) 4.0 $11M -47% 11M 1.01
 View chart
Paratek Pharmaceuticals Note 4.750% 5/0 (Principal) 2.7 $7.4M 9.0M 0.82
 View chart
Puma Biotechnology (PBYI) 2.0 $5.5M 1.8M 3.09
 View chart
Biora Therapeutics Ord 1.7 $4.7M NEW 1.7M 2.77
 View chart

Past Filings by Athyrium Capital Management

SEC 13F filings are viewable for Athyrium Capital Management going back to 2017

View all past filings